Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Market Value Is The Neurointerventional Devices Industry Expected To Reach By 2029, Starting From 2025 Levels?
The neurointerventional devices market has shown significant expansion in recent years. It is anticipated to expand from $2.57 billion in 2024 to $2.76 billion in 2025, progressing at a compound annual growth rate (CAGR) of 7.5%. The historical development of this market can be linked to factors such as increased recognition of early diagnosis, a growing number of dedicated neurointerventional centers, a rise in lifestyle-related illnesses like hypertension and diabetes, greater demand for superior patient outcomes, and enhanced support from public and private healthcare organizations.
The neurointerventional devices market is projected to experience substantial expansion in the coming years, with forecasts indicating a rise to $3.65 billion by 2029, driven by a compound annual growth rate (CAGR) of 7.2%. This anticipated growth can be attributed to several factors, including an increasing preference for image-guided surgical procedures, heightened investment in neurovascular research, a growing number of approvals for innovative neurointerventional products, expanding partnerships and acquisitions among device manufacturers, and a rising demand for personalized treatment approaches. Concurrently, major trends expected during this period involve advancements in robotic-assisted neurointerventions, continuous innovation in catheter and stent design, more sophisticated integration of artificial intelligence in diagnostic imaging, the incorporation of augmented reality into surgical planning, and novel developments in embolization and thrombectomy techniques.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25846&type=smp
What Are The Top Growth Drivers Impacting The Neurointerventional Devices Market Outlook?
The expanding occurrence of neurological disorders is anticipated to stimulate the development of the neurointerventional devices market moving forward. Such disorders encompass any ailment impacting the brain, spinal cord, or nerves, thereby interfering with their normal operation. The surge in these conditions is fueled by an increasingly older global populace, as advanced age elevates the susceptibility to neurodegenerative issues owing to the inherent decrease in brain function and cellular repair processes. Neurointerventional devices are instrumental in addressing neurological disorders by facilitating minimally invasive interventions for the diagnosis and management of conditions like brain aneurysms, strokes, and vascular malformations, consequently diminishing risks, shortening recovery periods, and enhancing patient results. For instance, in April 2024, a report from the Alzheimer’s Association, a US-based nonprofit voluntary health organization, indicated that in 2022, 6.5 million Americans aged 65 and older had an Alzheimer’s dementia diagnosis, a figure that climbed to 6.9 million in 2024. Consequently, the escalating prevalence of neurological disorders is powering the expansion of the neurointerventional devices market.
What Are The Major Segment Categories Driving The Neurointerventional Devices Market Growth?
The neurointerventional devices market covered in this report is segmented –
1) By Product: Embolic Coils, Carotid Stents, Intracranial Stents, Neurovascular Thrombectomy, Embolic Protection Device, Flow Diverters Device, Intrasaccular Device, Other Products
2) By Indication: Brain Aneurysm, Stroke, Other Indications
3) By Technique: Neurothrombectomy Procedure, Cerebral Angiography, Stenting, Coiling Procedures, Flow Disruption
4) By End User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Research Institutes
Subsegments:
1) By Embolic Coils: Bare Platinum Coils, Coated Or Modified Coils, Complex-Shaped Coils, Detachable Coils
2) By Carotid Stents: Open-Cell Stents, Closed-Cell Stents, Hybrid-Cell Stents, Drug-Eluting Stents
3) By Intracranial Stents: Self-Expanding Stents, Balloon-Expandable Stents, Drug-Eluting Stents
4) By Neurovascular Thrombectomy Devices: Stent Retrievers, Aspiration Catheters, Combined Thrombectomy Systems
5) By Embolic Protection Devices: Distal Filters, Proximal Occlusion Devices, Distal Occlusion Devices
6) By Flow Diverters Devices: Braided Flow Diverters, Dual-Layer Flow Diverters, Coated Flow Diverters
7) By Intrasaccular Devices: Woven Mesh Implants, Expandable Mesh Baskets, Flow Disrupting Implants
8) By Other Products: Microcatheters, Guidewires, Balloon Catheters, Distal Access Catheters
How Are Emerging Market Trends Shaping The Neurointerventional Devices Industry Landscape?
Major companies in the neurointerventional devices market are emphasizing technological advancements, such as AI-assisted navigation systems, to improve procedural accuracy, decrease intervention time, and enhance patient results in complex neurovascular treatments. These advanced systems utilize artificial intelligence algorithms to guide neurointerventional procedures in real time, analyzing medical imaging data to provide superior visualization, automate path planning, and assist in precisely navigating devices through intricate brain vasculature, thus boosting precision, reducing procedure duration, and minimizing associated risks. For instance, in October 2022, Medtronic plc, an Ireland-based healthcare technology company, launched the Medtronic Neurovascular Co Lab Platform to accelerate innovation in stroke care. This platform promotes collaboration among startups, physicians, and institutions, offering an always-on virtual portal where ideas can be submitted. These submissions are then evaluated and advanced through access to Medtronic’s expertise, funding, and networks to rapidly develop promising neurovascular solutions and improve patient outcomes.
Who Are The Prominent Global Companies Shaping The Neurointerventional Devices Market?
Major companies operating in the neurointerventional devices market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, Stryker Corporation, Boston Scientific Corporation, Terumo Corporation, Kaneka Corporation, Cook Medical LLC, Integra LifeSciences Holdings Corporation, Merit Medical Systems Inc., MicroPort Scientific Corporation, Penumbra Inc., Asahi Intecc Co. Ltd., MicroVention Inc., Phenox GmbH, Balton Sp. z o.o., Zylox-Tonbridge Medical Technology Co. Ltd., Balt Group SAS, Veiva Scientific Co. Ltd., InspireMD Inc.
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/neurointerventional-devices-global-market-report
Which Regional Markets Are Contributing Most To The Neurointerventional Devices Industry Expansion?
North America was the largest region in the neurointerventional market in 2024. The regions covered in the neurointerventional devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Neurointerventional Devices Market Report:
https://www.thebusinessresearchcompany.com/customise?id=25846&type=smp
Browse Through More Reports Similar to the Global Neurointerventional Devices Market 2025, By The Business Research Company
Neurology Devices Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/neurology-devices-global-market-report
Brain And Neuroimaging Devices Global Market Report 2025
Neurostimulation Devices Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/neurostimulation-devices-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model